Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Ideggyogyaszati Szemle
|
January 8, 2013
[Rivaroxaban in prevention of stroke in patients with atrial fibrillation]
Gábor Simonyi, Mihály Medvegy
Cardiology and Therapy
|
April 3, 2021
Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)
Mihály Medvegy, Gábor Simonyi
Orvosi Hetilap
|
February 5, 2013
[Instrumental therapy of drug-resistant hypertension]
Gábor Simonyi, J Róbert Bedros, Mihály Medvegy
Acta Physiologica Hungarica
|
September 7, 2011
Non-ST elevation myocardial infarction: a new pathophysiological concept could solve the contradiction between accepted cause and clinical observations
Mihály Medvegy, G Simonyi, N Medvegy, et al.
Orvosi Hetilap
|
May 5, 2020
Real-world adherence to oral anticoagulants in atrial fibrillation
Gábor Simonyi, András Paksy, Réka Várnai, et al.
Orvosi Hetilap
|
February 4, 2024
[Five-year persistence of statins after acute myocardial infarction in statin-naïve patients]
Gábor Simonyi, Tamás Ferenci, Ervin Finta, et al.
Orvosi Hetilap
|
February 29, 2012
[The pharmacological treatment of obesity: past, present and future]
Gábor Simonyi, Gyula Pados, Mihály Medvegy, et al.
Orvosi Hetilap
|
August 27, 2023
[One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients]
Gábor Simonyi, Tamás Ferenci, Ervin Finta, et al.
Orvosi Hetilap
|
September 5, 2017
[One year persistence of free and fixed dose combinations of perindopril/amlodipine]
Gábor Simonyi, Tamás Ferenci, Mihály Medvegy, et al.
Orvosi Hetilap
|
March 26, 2019
[One-year persistence of patients already treated with oral anticoagulants for atrial fibrillation]
Gábor Simonyi, Tamás Ferenci, Ervin Finta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Ideggyogyaszati Szemle
|
January 8, 2013
[Rivaroxaban in prevention of stroke in patients with atrial fibrillation]
Gábor Simonyi, Mihály Medvegy
Cardiology and Therapy
|
April 3, 2021
Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)
Mihály Medvegy, Gábor Simonyi
Orvosi Hetilap
|
February 5, 2013
[Instrumental therapy of drug-resistant hypertension]
Gábor Simonyi, J Róbert Bedros, Mihály Medvegy
Acta Physiologica Hungarica
|
September 7, 2011
Non-ST elevation myocardial infarction: a new pathophysiological concept could solve the contradiction between accepted cause and clinical observations
Mihály Medvegy, G Simonyi, N Medvegy, et al.
Orvosi Hetilap
|
May 5, 2020
Real-world adherence to oral anticoagulants in atrial fibrillation
Gábor Simonyi, András Paksy, Réka Várnai, et al.
Orvosi Hetilap
|
February 4, 2024
[Five-year persistence of statins after acute myocardial infarction in statin-naïve patients]
Gábor Simonyi, Tamás Ferenci, Ervin Finta, et al.
Orvosi Hetilap
|
February 29, 2012
[The pharmacological treatment of obesity: past, present and future]
Gábor Simonyi, Gyula Pados, Mihály Medvegy, et al.
Orvosi Hetilap
|
August 27, 2023
[One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients]
Gábor Simonyi, Tamás Ferenci, Ervin Finta, et al.
Orvosi Hetilap
|
September 5, 2017
[One year persistence of free and fixed dose combinations of perindopril/amlodipine]
Gábor Simonyi, Tamás Ferenci, Mihály Medvegy, et al.
Orvosi Hetilap
|
March 26, 2019
[One-year persistence of patients already treated with oral anticoagulants for atrial fibrillation]
Gábor Simonyi, Tamás Ferenci, Ervin Finta, et al.
Page
of 2